Thomas Stoeger

Thomas Stoeger

Auto-generated profile, based on publicly available information

Thomas Stoeger

The Potocsnak Longevity Institute, Northwestern University

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Cell
Verified
Journal Article
Closed access
NBNico Battich
Nico Battich
TSThomas Stoeger
Thomas Stoeger
LPLucas Pelkmans
Lucas Pelkmans

12 April 2009 in Nature
Verified
Journal Article
Closed access
PDF file
JMJennifer L. Mummery-Widmer
Jennifer L. Mummery-Widmer
MYMasakazu Yamazaki
Masakazu Yamazaki
TSThomas Stoeger
Thomas Stoeger
MNMaria Novatchkova
Maria Novatchkova
SBSheetal Bhalerao
Sheetal Bhalerao
JKJuergen A. Knoblich
Juergen A. Knoblich

6 October 2013 in Nature Methods
Verified
Journal Article
Closed access
NBNico Battich
Nico Battich
TSThomas Stoeger
Thomas Stoeger
LPLucas Pelkmans
Lucas Pelkmans

18 September 2018 in PLOS Biology
Verified
Journal Article
Open access
PDF file
TSThomas Stoeger
Thomas Stoeger
MGMartin Gerlach
Martin Gerlach
RMRichard I Morimoto
Richard I Morimoto
LALuís A Nunes Amaral
Luís A Nunes Amaral
Biomedical research has been previously reported to primarily focus on a minority of all known genes. Here, we demonstrate that these differences in attention can be explained, to a large extent, exclusively from a small set of identifiable chemical, physical, and biological properties of genes. Together with knowledge about homologous genes from model organisms, these features allow us to accurately predict the number of publications on individual human genes, the year of their first report, the levels of funding awarded by the National Institutes of Health (NIH), and the development of drugs against disease-associated genes. By explicitly identifying the reasons for gene-specific bias and performing a meta-analysis of existing computational and experimental knowledge bases, we describe gene-specific strategies for the identification of important but hitherto ignored genes that can open novel directions for future investigation. Biomedical research is one of the largest areas of present-day science and embeds the hope and potential to improve the lives of the general public. In order to understand how individual scientists choose individual research questions, we study why certain genes are well studied but others are not. While it has been previously observed that most research on human genes only concentrates on approximately 2,000 of the 19,000 genes of the human genome, the reasons for this ignorance are largely unknown. We systematically test explanations for this observation by compiling an extensive resource that characterizes biomedical research, including but not limited to hundreds of chemical and biological properties of gene-encoded proteins, and the published scientific literature on individual genes. Using machine learning methods, we can predict the number of publications on individual genes, the year of the first publication about them, the extent of funding by the National Institutes of Health, and the existence of related medical drugs. We find that biomedical research is primarily guided by a handful of generic chemical and biological characteristics of genes, which facilitated experimentation during the 1980s and 1990s, rather than the physiological importance of individual genes or their relevance to human disease.

15 February 2021 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
AMAlexandra C. McQuattie-Pimentel
Alexandra C. McQuattie-Pimentel
ZRZiyou Ren
Ziyou Ren
NJNikita Joshi
Nikita Joshi
SWSatoshi Watanabe
Satoshi Watanabe
TSThomas Stoeger
Thomas Stoeger
GBG.R. Scott Budinger
G.R. Scott Budinger
Alveolar macrophages orchestrate the response to viral infections. Age-related changes in these cells may underlie the differential severity of pneumonia in older patients. We performed an integrated analysis of single-cell RNA-Seq data that revealed homogenous age-related changes in the alveolar macrophage transcriptome in humans and mice. Using genetic lineage tracing with sequential injury, heterochronic adoptive transfer, and parabiosis, we found that the lung microenvironment drove an age-related resistance of alveolar macrophages to proliferation that persisted during influenza A viral infection. Ligand-receptor pair analysis localized these changes to the extracellular matrix, where hyaluronan was increased in aged animals and altered the proliferative response of bone marrow–derived macrophages to granulocyte macrophage colony-stimulating factor (GM-CSF). Our findings suggest that strategies targeting the aging lung microenvironment will be necessary to restore alveolar macrophage function in aging.

4 August 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
RRReese A. K. Richardson
Reese A. K. Richardson
SHSpencer S. Hong
Spencer S. Hong
JBJennifer A. Byrne
Jennifer A. Byrne
TSThomas Stoeger
Thomas Stoeger
LALuís A. Nunes Amaral
Luís A. Nunes Amaral
Science is characterized by collaboration and cooperation, but also by uncertainty, competition, and inequality. While there has always been some concern that these pressures may compel some to defect from the scientific research ethos—i.e., fail to make genuine contributions to the production of knowledge or to the training of an expert workforce—the focus has largely been on the actions of lone individuals. Recently, however, reports of coordinated scientific fraud activities have increased. Some suggest that the ease of communication provided by the internet and open-access publishing have created the conditions for the emergence of entities—paper mills (i.e., sellers of mass-produced low quality and fabricated research), brokers (i.e., conduits between producers and publishers of fraudulent research), predatory journals, who do not conduct any quality controls on submissions—that facilitate systematic scientific fraud. Here, we demonstrate through case studies that i) individuals have cooperated to publish papers that were eventually retracted in a number of journals, ii) brokers have enabled publication in targeted journals at scale, and iii), within a field of science, not all subfields are equally targeted for scientific fraud. Our results reveal some of the strategies that enable the entities promoting scientific fraud to evade interventions. Our final analysis suggests that this ability to evade interventions is enabling the number of fraudulent publications to grow at a rate far outpacing that of legitimate science.